Home/Biotron/Dr Michelle Miller
DM

Dr Michelle Miller

Chief Executive Officer and Managing Director

Biotron

Therapeutic Areas

Biotron Pipeline

DrugIndicationPhase
BIT225HIV‑1Phase 2
Preclinical ProgramDengue VirusPreclinical